PER 0.00% 8.4¢ percheron therapeutics limited

Ann: First approval for ATL1102 Phase IIb DMD clinical trial, page-8

  1. 3,594 Posts.
    lightbulb Created with Sketch. 779
    Ok lets looks forward:

    Incoming news:

    1. New CEO .....Anytime
    2. Combo results ...Next 6 weeks  max ( Now this is big as its going to suggest the key data on Dystrophin levels and other cell markers
    3. LC partnership with some $$ attached ...Anytime ...Hopefully we get this news and time has not been wasted on this research and trials
    4. UK and Bulgaria approvals ...Anytime as submission may have been done at the same time
    5. First Dosing ....Anytime...Exciting....
    6. Any other unexpected news...Anytime...lol

    glh...
    Last edited by arjay: 14/02/23
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.000(0.00%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.5¢ 8.4¢ $13.08K 155.4K

Buyers (Bids)

No. Vol. Price($)
2 12500 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 195437 3
View Market Depth
Last trade - 11.32am 30/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.